Ann: One-hundredth patient recruited in VF001002 clinical trial, page-3

But it's taking ages to recruit people for the trial which makes me concerned that the product isn't in much demand after years of delays while competition progressed. Then the trial is being limited by a very selective recruitment process possibly followed by an outcome that won't meet expectations and not much in the way of other products. I'm cheesed off after having money tied up in FTT for years while the correction in the market presents more promising buying opportunities elsewhere.